NCT04669821View on ClinicalTrials.gov

A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 9, 2021

Primary Completion Date

August 28, 2021

Study Completion Date

October 9, 2021

Conditions
Sedation in Intensive Care
Interventions
DRUG

HSK3486

Loading Dose：0.1 mg/kg，Maintenance Dose：Maintenance is started at 0.3 mg/kg/h, and the dose can be adjusted up and down by 0.05-0.1 mg/kg/h.

DRUG

Propofol

Loading Dose：0.5 mg/kg，Maintenance Dose：Maintenance is started at1.5 mg/kg/h, and the dose can be adjusted up and down by 0.25-0.5mg/kg/h.

Trial Locations (1)

Unknown

The First Affiliated Hospital of Xinjiang Medical University, Xinjiang

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT04669821 - A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation | Biotech Hunter | Biotech Hunter